Brief: Galapagos Appoints Aaron Cox As CFO
June 23 (Reuters) - Galapagos NV GLPG.AS: APPOINTS AARON COX AS CFO EFFECTIVE JULY 7, 2025 THAD HUSTON TO REMAIN WITH GALAPAGOS UNTIL JULY 31, 2025 TO ISSUE NEW RSUS AND SUBSCRIPTION RIGHTS Source text: ID:nGNX2TfGV1 Further company coverage: GLPG.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline